Inhibition of the cGAS‑STING Pathway Reduces Cisplatin-Induced Inner Ear Hair Cell Damage.
10.1007/s12264-024-01334-8
- Author:
Ying SUN
1
;
Shengyu ZOU
1
;
Xiaoxiang XU
1
;
Shan XU
2
;
Haiying SUN
3
;
Mingliang TANG
4
;
Weijia KONG
3
;
Xiong CHEN
5
;
Zuhong HE
6
,
7
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
2. Department of Otolaryngology, The First Hospital of China Medical University, Shenyang, 110001, China.
3. Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
4. Institute for Cardiovascular Science and Department of Cardiovascular Surgery of the First Affiliated Hospital, Suzhou Medical College of Soochow University, Soochow University, Suzhou, 215000, China.
5. Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. zn_chenxiong@whu.edu.cn.
6. Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. hezuhong@
7. com.
- Publication Type:Journal Article
- Keywords:
Hair cell;
Hearing loss;
Mitochondrial dysfunction;
Ototoxicity;
cGAS-STING
- MeSH:
Cisplatin/toxicity*;
Animals;
Nucleotidyltransferases/antagonists & inhibitors*;
Membrane Proteins/antagonists & inhibitors*;
Signal Transduction/drug effects*;
Mice;
Hair Cells, Auditory, Inner/pathology*;
Antineoplastic Agents/toxicity*;
Mice, Inbred C57BL;
Hearing Loss/metabolism*;
Male;
Ototoxicity/metabolism*
- From:
Neuroscience Bulletin
2025;41(3):359-373
- CountryChina
- Language:English
-
Abstract:
Although cisplatin is a widely used chemotherapeutic agent, it is severely toxic and causes irreversible hearing loss, restricting its application in clinical settings. This study aimed to determine the molecular mechanism underlying cisplatin-induced ototoxicity. Here, we established in vitro and in vivo ototoxicity models of cisplatin-induced hair cell loss, and our results showed that reducing STING levels decreased inflammatory factor expression and hair cell death. In addition, we found that cisplatin-induced mitochondrial dysfunction was accompanied by cytosolic DNA, which may act as a critical linker between the cyclic GMP-AMP synthesis-stimulator of interferon genes (cGAS-STING) pathway and the pathogenesis of cisplatin-induced hearing loss. H-151, a specific inhibitor of STING, reduced hair cell damage and ameliorated the hearing loss caused by cisplatin in vivo. This study underscores the role of cGAS-STING in cisplatin ototoxicity and presents H-151 as a promising therapeutic for hearing loss.
